Retatrutide 20mg
Triple GLP-1/GIP/GCG agonist · 20mg vial
Also known as: LY3437943, triple-agonist (20mg research vial)
Supplied for laboratory and research purposes only. Not for human consumption. Storage: 2 to 8°C after reconstitution; ambient until opened.
What is Retatrutide?
The 20mg vial of retatrutide — the same investigational triple agonist as the 10mg presentation, sized for longer research runs.
What it's studied for
Retatrutide has activity at the GLP-1, GIP and glucagon receptors. The larger vial is the lower cost-per-milligram option where a protocol needs volume; it is the same lot-tested material as the 10mg vial. Investigational compound, not an approved medicine.
Storage & handling
Supplied lyophilised. Reconstitute with bacteriostatic water for laboratory use; store at 2-8°C once in solution and avoid repeated freeze-thaw cycles.
Work out the concentration for a given solvent volume, or read the full reconstitution guide.
Independently HPLC tested (99.1%). Certificate of Analysis available on request where one is on file for the lot. Supplied for laboratory and research purposes only. Not for human consumption, not for therapeutic or diagnostic use.
